Related Experiment Video
Updated: May 29, 2026

Fentanyl Analog Screening using LC-TIMS-TOF MS/MS
Published on: November 8, 2024
Disaster after the plaster. Fentanyl withdrawal symptoms in a curable hospice patient
M Hugo J Maathuis1, Daniel D P Dijkstra
1Department of Primary and Community Care Medicine, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. h.maathuis@elg.umcn.nl
Abstract:
Opioids have been used for thousands of years for pain relief. Transdermal fentanyl (TDF) is a synthetic opioid that is prescribed for the treatment of chronic pain. This clinical lesson demonstrates that TDF may be easy to start but sometimes difficult to stop. Like any other opioid there is a substantial risk of physical dependence and subsequent withdrawal symptoms after discontinuation of the drug. Here, we present a case of a hospice patient who developed withdrawal symptoms after a first TDF tapering attempt according to the manufacturer's instructions. A second, more gradual tapering regimen did not result in withdrawal symptoms. The mechanisms and treatment modalities for physical dependence along with a tailor-made tapering strategy that is suitable for general practice are presented in this clinical lesson.
Related Concept Videos
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Continuing Care
Pharmaceutical Poisoning: Treatment Strategies
Pharmaceutical Poisoning: Potential Scenarios
Restorative Care
Analgesia and Pain Management

